Seeing Is Believing
First Wave BioPharma's activity chart (see below) currently has 13 price targets and 24 ratings on display.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 30.33 days.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 25-Mar-2024. First documented stock forecast 17-Oct-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 25-Mar-2024
2 years 7 months 7 days ago
(25-Mar-2024)
0/4 (0%)
$251.6 (232.10%)
Buy Since 01-Apr-2021
2 years 9 months 29 days ago
(03-Jan-2024)
0/3 (0%)
$2070.63 (482.25%)
Hold Since 10-Dec-2021
$126000.25
4 years 10 months 22 days ago
(10-Dec-2021)
0/3 (0%)
$96507.95 (327.23%)
Buy Since 17-Oct-2018
$336000.66
$335997.69 (11275090.00%)
$252000.5
7 years 8 months 6 days ago
(26-Feb-2019)
0/2 (0%)
$247469.2 (279.53%)
What is FWBI (First Wave BioPharma) average time for price targets to be met?
Which analyst most recently updated their price target on FWBI (First Wave BioPharma)?
Which analyst has the current lower performing score on FWBI (First Wave BioPharma) with a proven track record?
Which analyst has the most public recommendations on FWBI (First Wave BioPharma)?
Which analyst is the currently most bullish on FWBI (First Wave BioPharma)?
Which analyst is the currently most reserved on FWBI (First Wave BioPharma)?